The AI pathology quality control market is projected to grow significantly by 2029, driven by increased cancer incidence and demand for diagnostic accuracy. Key advancements include the integration of AI in pathology workflows and personalized medicine approaches, particularly in the U.S. and Europe, enhancing cancer diagnosis efficiency.
Read More:
- đ finance.yahoo.com